메뉴 건너뛰기




Volumn 23, Issue 33, 2005, Pages 8543-8544

Computer modeling is no substitute for randomized clinical trials for decision making in early breast cancer hormonal therapy [7]

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

EID: 33644670156     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.7374     Document Type: Letter
Times cited : (2)

References (5)
  • 1
    • 24644446997 scopus 로고    scopus 로고
    • Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: A decision analysis
    • Punglia RS, Kuntz KM, Winer EP, et al: Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: A decision analysis. J Clin Oncol 23:5178-5187, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 5178-5187
    • Punglia, R.S.1    Kuntz, K.M.2    Winer, E.P.3
  • 2
    • 0037157603 scopus 로고    scopus 로고
    • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial
    • Baum M, Buzdar AU, Cuzick J, et al: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139, 2002
    • (2002) Lancet , vol.359 , pp. 2131-2139
    • Baum, M.1    Buzdar, A.U.2    Cuzick, J.3
  • 3
    • 10744223655 scopus 로고    scopus 로고
    • A randomized trial of exemestane after two or three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    • Coombes RC, Hall E, Gibson LJ, et al: A randomized trial of exemestane after two or three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1090, 2004
    • (2004) N Engl J Med , vol.350 , pp. 1081-1090
    • Coombes, R.C.1    Hall, E.2    Gibson, L.J.3
  • 4
    • 7444259675 scopus 로고    scopus 로고
    • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
    • Goss PE, Ingle JN, Martino S, et al: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793-1802, 2003
    • (2003) N Engl J Med , vol.349 , pp. 1793-1802
    • Goss, P.E.1    Ingle, J.N.2    Martino, S.3
  • 5
    • 27344435722 scopus 로고    scopus 로고
    • Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer
    • suppl, abstr 658, 43s
    • Cuzick J, Howell A: Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer. J Clin Oncol 23:43s, 2005 (suppl, abstr 658)
    • (2005) J Clin Oncol , vol.23
    • Cuzick, J.1    Howell, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.